The global Continuous Glucose Monitoring (CGM) Systems Market is projected to expand significantly, rising from USD 12,835.6 million in 2025 to USD 55,048.4 million by 2035, registering a compound annual growth rate (CAGR) of 15.7%. In 2024, the market generated USD 11,096.4 million in revenue.
After 15 years covering health tech, here’s the blunt truth: continuous glucose monitoring (CGM) is a game-changer. Yet, despite explosive market growth, the system is failing millions. The technology is there, but the people who need it most? They’re left behind.
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-694
Innovation Is Racing Ahead—but Safety Is Playing Catch-Up
CGMs are shrinking, going wireless, and syncing to smartphones. Sounds great, right? It is—until critical alerts fail, or data glitches lead to dangerous misreads. This isn’t a minor bug. It’s a potential death sentence.
The market and regulators are in a dangerous race to innovate without a safety net. This needs to stop. Fast.
Global Access Is a Mirage for Millions
The FMI report shows rapid growth across Europe and Asia, but what about the places where diabetes is rising fastest? Low- and middle-income countries? Forget it. CGMs are luxuries for the wealthy.
And here at home? The high costs, insurance red tape, and lack of awareness create a cruel barrier for many. The tech isn’t just advanced—it’s advanced beyond the reach of those who need it most.
Key Segments
By Components:
- Transmitters and Monitors
- Sensors and Insulin Pump
By End-use Sector:
- Home Care Diagnostics
- Hospitals and ICU/Critical Care
Explore In-Depth Analysis-Click Here to Access the Report:- https://www.futuremarketinsights.com/reports/continuous-glucose-monitoring-systems-market
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
